harvard-mba
(51)
Srinath Sridhar
Srinath Sridhar is the co-founder and CEO of Regie.ai, an AI-native sales engagement platform based in San Francisco that automates prospecting and generates personalized outbound campaigns for enterprise sales teams. A computer scientist with a PhD in algorithms and machine learning from Carnegie Mellon and an MBA from Harvard, he spent time on Facebook's early engineering team and was a founding engineer at BloomReach before co-founding the supply-chain company Onera. He now argues for a humanistic approach to AI, one that hands routine work to machines so people can do the creative parts.
Clay Ritchey
Clay Ritchey is the Chief Executive Officer of Verato, a Tysons, Virginia healthcare technology company whose referential identity matching platform helps hospitals, life science firms and government agencies resolve who is who across fragmented records. A Penn State electrical engineer and Harvard MBA, he has spent more than two decades building and scaling healthcare software businesses, including a turn as CEO of Evariant, which merged with Healthgrades in 2020. He took the helm at Verato in 2021 and has become a frequent voice on why patient matching sits at the center of healthcare's digital transformation.
Don Spear
Don Spear is the co-founder and CEO of OpenSesame, the Portland-based marketplace that lets companies find, buy, and manage elearning courses the way people buy songs on iTunes. A Rice University engineer and Harvard MBA, he spent decades scaling companies - from PetSmart through its IPO to Banfield Pet Hospital's expansion from 4 to 250 locations - before founding BlueVolt and then OpenSesame in 2010. Today he leads a catalog of tens of thousands of courses and an AI-driven push to make workplace learning easier to find and use.
John Clendening
John Clendening is the founder and CEO of Earned (Earned Wealth), a tech-enabled financial services firm built exclusively for doctors, dentists, and their medical practices. After more than two decades running large financial businesses, including a stint as CEO of Blucora and senior leadership at Charles Schwab where he ran Schwab Bank, he started Earned to fold wealth management, tax, accounting, insurance, and practice services into a single platform for healthcare professionals. The company has raised roughly $225 million and grown past 240 employees, and it landed on Newsweek and Forbes advisory-firm rankings in 2025.
Nick Patrick
Nick Patrick is the co-founder and CEO of Radar, a New York-based location platform that provides geofencing SDKs, maps APIs and geocoding services to companies like Panera, DICK's Sporting Goods, T-Mobile and Zillow. He started Radar in 2016 with Coby Berman after meeting him at Foursquare, and has raised more than $85 million from Accel, Insight Partners, Two Sigma Ventures, Expa and Heavybit. Before Radar he was Senior Director of Product at Handy and a product manager at Foursquare and Microsoft.
Sam Li
Sam Li is co-founder and CEO of Thoropass, the New York-based information security compliance and audit platform formerly known as Laika. He grew up in Shanghai, studied computer science and economics at the University of Virginia, worked at Goldman Sachs and Google, dropped out of Harvard Business School to run a YC-backed insurtech called Zinc Platform, watched it die, spent a year as an EIR at Bain Capital Ventures, then in 2019 co-founded a company to make SOC 2 audits less miserable. Thoropass has raised roughly $98 million across four rounds and now combines software with a licensed audit practice.
Toffer Winslow
Toffer Winslow is the CEO and a board member of Diffblue, an Oxford-spun AI company that uses reinforcement learning - not large language models - to automatically write unit tests for Java code, at a pace of roughly one test every two seconds. A three-decade enterprise-software operator, he has run go-to-market and led companies through the growth-and-exit cycle at Dynatrace, RSA Security, Lavastorm, Tamr, and StackState (which he steered into an acquisition by SUSE). At Diffblue he is selling deterministic, on-premises AI to some of the most security-anxious buyers on earth: four of the ten largest U.S. banks, plus Citi, ING, Cisco, AstraZeneca, and BNY Mellon.
Yoni Shtein
Yoni Shtein is the CEO and co-founder of Laguna Health, a New York and Tel Aviv company building conversational AI copilots for payer care teams. Born in Chisinau and raised across continents, he moved from an elite Israeli Air Force unit to writing code at Microsoft, then to running more than half a billion dollars of investments before turning entrepreneur. Laguna landed on TIME's Best Inventions of 2024. Shtein pairs an investor's skepticism with a runner's stamina and an immigrant's comfort with the unfamiliar.
Austin Oehlerking
Austin Oehlerking is the co-founder and CEO of Boxbot, an Alameda, California robotics company reinventing how parcels are stored, sorted, and sequenced inside the supply chain. A mechanical engineer trained at MIT with a Harvard MBA, he cut his teeth building electric vehicles at Arcimoto and Tesla before starting Boxbot in 2016 as a self-driving last-mile delivery venture. When customers proved more excited about the box-handling robot than the delivery van, Oehlerking pivoted the company toward AI-driven, high-density parcel storage, turning the flat conveyor belt into a three-dimensional machine. Boxbot has raised roughly $28-29.5M from Playground Global, Toyota Ventures, Maersk Growth, Pear Ventures, and Artiman Ventures.
Qiyun Cai
Qiyun Cai is the co-founder and CEO of Fintary, an AI-powered financial operations platform that automates commission processing for insurance agencies and carriers. A Harvard MBA and former insurance-brokerage founder (Amplify Life), she built Fintary after years of reconciling commissions by hand, reframing a back-office headache as a growth engine. Fintary has raised $12.8M, including a $10M Series A led by Infinity Ventures, and processes over $500M in annual commissions for 50+ insurance organizations.
Justin Dawe
Justin Dawe is the founder and CEO of Earth Force Technologies, a San Francisco climate-tech company building in-cabin sensor tablets and a web portal that give forestry operators real-time, tree-level guidance for wildfire prevention and forest restoration. A Stanford-trained engineer and Harvard MBA, he has spent more than two decades in climate and mobility ventures, including roles as CEO of Scoot Networks, VP of New Ventures at Bird, and founding CEO of C12 Energy. Earth Force has raised about $8.6M in seed funding from BOLD Capital Partners, Alley Robotics Ventures, and others.
Linda Finkel
Linda Finkel is a healthcare technology executive who runs OutcomesAI, a Boston-based company pairing AI voice agents with licensed nurses to expand nursing capacity through its Glia engine. Before OutcomesAI she spent over a decade building AVIA into the country's leading digital transformation partner for health systems, first as president from 2014 and then as CEO from 2020. A Stanford BA and Harvard MBA, she earlier ran large international services companies including Bowne Business Solutions and Donnelley Business Services, and pivoted to healthcare after watching her father's 91-day ICU stay reveal both the heroism and the gaps in modern care. She has been named one of the Top 50 Women Leaders in Healthcare.
Brad Peters
Brad Peters is a serial analytics founder who has spent more than two decades trying to put real data science in the hands of people who do not write SQL. He founded Birst, one of the first cloud business intelligence platforms, grew it into a Gartner Magic Quadrant leader, and exited to Infor for $580 million in 2017. He is now founder and CEO of Scoop Analytics, a San Francisco startup building an AI 'data analyst' that connects to operational tools, investigates data on its own, and tells the story back to non-technical business users. He earlier helped build the analytics product line at Siebel Systems that became Oracle's OBIEE family, and started his career in Morgan Stanley's M&A practice.
David Friedeberg
David Friedeberg is the founder and CEO of OXOMIO, a wellness and supplements company that pairs Earth's purest natural ingredients with biotechnology under the banner 'The Luxury of Wellness.' Son of Mexican surrealist Pedro Friedeberg, David grew up in an artist's household where making something from nothing was a daily ritual, then carried that mindset through a career that spanned fine-art dealing, hospitality operations, and a Harvard MBA before launching OXOMIO in 2017. He splits his life between San Miguel de Allende, Mexico and Austin, Texas, and runs his days by the Japanese principle of kenkou dai-ichi - health above everything else.
Drew Ladner
Drew Ladner is the founding Chairman and CEO of Pascal Metrics, a Washington, D.C. and Austin-based patient safety company that uses real-time EHR data, clinically validated adverse-event outcomes, and machine learning to catch preventable harm in hospitals before it compounds. Since 2007 he has built Pascal into a U.S.-certified Patient Safety Organization serving hundreds of healthcare systems worldwide, with clients identifying roughly 10x more serious harm than legacy methods. Before healthcare, he was CIO of the U.S. Treasury's $2.6 billion IT organization, a general manager at open-source pioneer JBoss, and an operator across Netscape, AOL Time Warner, and microfinance in East Africa. He holds an MBA from Harvard, an MA in theology from Oxford, and a BSFS from Georgetown.
Ephraim Luft
Ephraim Luft is the co-founder and CEO of Togetherhood, a New York-based platform that helps schools, residential buildings and community spaces source, schedule and manage high-quality enrichment programs taught by vetted independent teaching artists and coaches. He built the company with his wife Danielle after pandemic remote learning collapsed for their own family in 2020, prompting them to rent space, hire teachers and build a classroom from scratch. Before Togetherhood, Ephraim was Chief Product Officer at luxury fashion platform Farfetch, where he sat on the executive board through its roughly $7B IPO, and earlier co-founded and led Circle of Moms, a parenting social network acquired by POPSUGAR in 2012. He holds a B.S. in Computer Science from Stanford and an MBA from Harvard Business School.
Ly Tran
Ly Tran is the CEO of Belle.ai (BelleTorus Corporation), a Cambridge, Massachusetts computer vision company whose AI reads smartphone photos to help clinicians evaluate more than 1,600 skin conditions across 60-plus countries. He took the helm in 2021 after co-founding AtHoc, the crisis-communications company he built into the top supplier to the U.S. Defense and Homeland Security markets before BlackBerry acquired it in 2015. A Princeton history graduate with a Harvard MBA, Tran pairs a go-to-market operator's instincts with board and investor roles at companies like Jane Technologies and Cirkul.
Manny Medina
Manny Medina is the co-founder and CEO of Paid, a London-based platform that lets companies bill for AI agents based on the value they deliver instead of per-seat fees. Before Paid he built Outreach, the sales engagement company he grew from a near-dead recruiting marketplace into a business worth $4.4 billion with roughly $250 million in recurring revenue. An Ecuadorian computer engineer who was an early employee on what became AWS and spent six years at Microsoft, Medina is now betting that the seat-based SaaS pricing model is obsolete and that the agent economy needs a way to get paid.
Michael Lai
Michael Lai is the CEO and co-founder of Sitejabber, a consumer review platform that has served more than 100 million shoppers and collected over 10 million reviews, and of SmartCustomer, an unbiased brand discovery tool launched in 2025. A Stanford computer scientist and Harvard MBA, he started Sitejabber in 2007 after a co-founder couldn't tell whether an online medical-equipment seller was a scam. His work sits at the intersection of consumer trust, transparency, and the messy fight against fake reviews and AI-generated content.
Scott Greenberg
Scott Greenberg is the Chief Business Officer of Nura Bio, a clinical-stage biopharmaceutical company in South San Francisco building small-molecule drugs to stop nerves from dying. He joined in February 2025 to steer business development and corporate strategy as the company pushes its lead SARM1 inhibitor, NB-4746, into the clinic. He arrives with more than two decades crossing the line between finance and biology - a Goldman Sachs banking start, more than a decade at Celgene, an operations leadership role at Roivant Sciences, and a stint as Chief Operating Officer at Aro Biotherapeutics. He studied both Finance and the Biological Basis of Behavior at the University of Pennsylvania before an MBA at Harvard.
Alex Martin
Alex Martin is the Chief Executive Officer of Abcuro, a clinical-stage biotech in Newton, Massachusetts working on selectively depleting highly cytotoxic T cells in autoimmune disease and cancer. A biopharma operator with more than 30 years of company-building and deal-making, he has run Palladio Biosciences and Realm Therapeutics (both acquired), served as COO of Intercept Pharmaceuticals and CFO of BioXell, and held business-development leadership at Novartis. In February 2025 he steered Abcuro to a $200 million Series C led by New Enterprise Associates. He also chairs the board of Veralox Therapeutics, sits on the board of ESSA Pharma, coaches senior executives, and lectures at Wharton and Columbia Business School.
Alex Sambvani
Alex Sambvani is the co-founder and CEO of Slang.ai, a New York voice-AI company that answers the phone for restaurants so staff don't have to. A Stanford-trained mechanical engineer with a Harvard MBA, he met co-founder Gabriel Duncan on Spotify's data science team, where the two won a company-wide hackathon with a personality-forward voice app. He turned a childhood love of cooking and robotics into a company that has handled more than 25 million guest calls for over 2,000 restaurant locations. Slang.ai has raised roughly $68 million across its rounds, including a $36 million Series B, with backers ranging from Homebrew and Underscore VC to chef Tom Colicchio.
Frederic Dijols
Frederic Dijols is the co-founder and CEO of Mixlab, a veterinary-exclusive pet pharmacy that compounds custom medications and delivers them fast and free to pet parents and the vets who prescribe them. A French-trained engineer with degrees from Ecole Polytechnique, Stanford, and Harvard Business School, he traded a healthcare-banking seat at J.P. Morgan for a pharmacy floor after a miserable experience getting meds for his aging pug, Bob. Since 2017 he has raised roughly $46.5M and built Mixlab into a multi-state operation pairing pharmacist-grade compounding with consumer-grade delight.
Jaimeson Rice
Jaimeson Rice is the CEO of Pinwheel, the New York fintech that has positioned itself as the income layer for financial services, connecting banks and fintechs to over 1,500 payroll platforms covering nearly 80% of U.S. paychecks. He stepped into the top job in July 2025 after three years as the company's CFO and chief of staff, succeeding co-founder Kurtis Lin. A Princeton engineer and Harvard MBA who passed through Goldman Sachs and Bain before founding his own SaaS CRM startup, Vlaris, Rice is now steering Pinwheel through marquee wins with KeyBank, Robinhood, DoorDash, and MoneyLion and the launch of its Switch Kit and Bill Navigator products.
Michael Choukas
Michael Choukas is the co-founder and CEO of Autem Therapeutics, a Hanover, New Hampshire biotech building AutEMsys, a bioelectric platform that delivers personalized, amplitude-modulated electromagnetic frequencies to treat solid tumor cancers. A Dartmouth and Harvard Business School graduate, he spent two decades running clinical-development, real-world-data, and oncology-analytics businesses at firms like ConcertAI, Vector Oncology, United BioSource, SCIREX and Bain & Company, work he credits with more than $2.5 billion in market value creation. He raised a $10 million Series A-1 in 2022 and is steering Autem toward FDA-cleared trials in liver cancer and glioblastoma.
Michael Konialian
Michael Konialian is the founder and CEO of Modern Life, an AI-powered life insurance brokerage built for financial advisors. After a winding path from aerospace structures at NASA to nuclear diplomacy at the U.S. State Department to scaling CoverWallet's advisor business into an Aon acquisition, he was floored by how confusing, invasive, and outdated it was to buy life insurance for his own family. Modern Life is his answer: a single dashboard that lets advisors pull instant quotes from 30-plus carriers and compress a process that once took six months into minutes. In November 2025 the company raised a $20M Series A led by Thrive Capital, bringing total funding to $35M.
Valentina Ratner
Valentina Ratner is the co-founder and CEO of AllSpice.io, the 'GitHub for hardware' that brings version control, collaboration, and automated design review to the engineers who build PCBs, schematics, and bills of materials. An Argentina-born mechanical engineer turned Amazon PM turned Harvard MS/MBA, she launched AllSpice after watching brilliant teams build complex machines on archaic, file-shuffling workflows. In June 2025 she raised a $15M Series A to take the company's AI design-validation agent out of private beta, with customers spanning Blue Origin, Bose, and Tools for Humanity.
Damaris Skouras
Damaris Skouras is the founder, chairman, and CEO of Olatec Therapeutics, a New York clinical-stage biopharmaceutical company built around dapansutrile, an oral, specific NLRP3 inflammasome inhibitor she has pushed from the lab bench into Phase 2 trials spanning gout, melanoma, type 2 diabetes, and Parkinson's disease. She started in finance as a Wall Street biotech banker in 1982, founded her own investment advisory firm in 1985, and eventually crossed the table to run the kind of company she used to finance. With a Stanford degree, a Harvard MBA, and the immunologist who discovered interleukin-1 as her co-founder, she has raised over $100 million to bet that a single inflammatory switch can be turned off across a range of diseases.
Dave Icke
Dave Icke is the CEO of Medisafe, the medication engagement platform that helps more than ten million patients stay on their treatments. A chemical engineer turned digital-health operator, he has spent two decades turning hardware and software into tools that keep people healthier: founding CEO of wearable biosensor company mc10, launcher of Becton Dickinson's digital health business, VP of Digital Health Product at Humana, and executive chair of mental-health AI company ieso. In 2025 he took the reins at Medisafe from founder Omri Shor to scale medication engagement across the global pharmaceutical ecosystem.
Mohit Rawat
Mohit Rawat is the Boston-based CEO of Myricx Bio, a UK-US biotech building a first-in-class antibody-drug conjugate platform based on NMT inhibition to treat cancer. He arrived in September 2025 fresh off Fusion Pharmaceuticals' $2.4 billion sale to AstraZeneca, where he was President and Chief Business Officer. With a Harvard MBA, an MIT chemical engineering master's, and stints at Novartis, AbbVie and McKinsey, he is steering Myricx toward its first human clinical trials in 2026.